Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3

Most cancer‐related deaths are a result of metastasis. The development of small molecular inhibitors reversing cancer metastasis represents a promising therapeutic opportunity for cancer patients. This pan‐cancer analysis identifies oncogenic roles of membrane‐associated phosphatidylinositol transfe...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zihao, Shi, Yu, Lv, Li, Chen, Jianing, Jiang, WenG., Li, Jun, Lin, Qun, Fang, Xiaolin, Gao, Jingbo, Liu, Yujie, Liu, Qiang, Xu, Xiaoding, Song, Erwei, Gong, Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762305/
https://www.ncbi.nlm.nih.gov/pubmed/36285700
http://dx.doi.org/10.1002/advs.202204649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762305/
https://www.ncbi.nlm.nih.gov/pubmed/36285700
http://dx.doi.org/10.1002/advs.202204649

Ejemplares similares